~Margaret Carthy, McAlister Marshall and Andrew Senn Assume Executive Leadership Roles~
PLANO, TEXAS – Jan. 10, 2022 – Integer Holdings Corporation (NYSE: ITGR), a leading medical device outsource (MDO) manufacturer, today announced the addition of three associates to its Executive Leadership Team (ELT). As part of a planned transition due to retirements, Margaret Carthy is being promoted to Senior Vice President, Quality and Regulatory Affairs and Andrew Senn is being promoted to Senior Vice President, Strategy and Business Development. In addition, McAlister “Mac” Marshall has assumed the role of Senior Vice President, General Counsel, Chief Ethics and Compliance Officer and Corporate Secretary, which he previously held on an interim basis. All three individuals will report to Integer President and CEO Joe Dziedzic.
“I’m thrilled to have these exemplary leaders on Integer’s Executive Leadership Team,” said Dziedzic. “Their collective expertise, skillsets and critical knowledge of the medical device industry complement our existing ELT, and the fact that all have held leadership roles within Integer is a testament to the strength of our culture and the breadth and depth of talent and capabilities within our organization.”
Margaret Carthy’s promotion to Senior Vice President, Quality and Regulatory Affairs comes as a result of Joseph Flanagan’s retirement from Integer in December 2021. She was previously Vice President, Quality and Regulatory for Integer, and has been with the organization since 2004. Before joining Integer, Margaret was a Quality & Regulatory Leader for the European Region at Sola International, now Carl Zeiss. Margaret holds a Bachelor of Science in Information Technology from Dublin City University, has a certification in Applied Chemistry from Waterford Institute of Technology, and is a Certified ISO 13485:2016 Lead Auditor.
Andrew Senn’s promotion to Senior Vice President, Strategy and Business Development comes in preparation for the retirement of Tony Borowicz, Senior Vice President, Strategy, Business Development and Investor Relations in early 2023. During Andrew’s 15-year career with Integer, he has held leadership positions in marketing, strategy, research and development, and commercial sales. Most recently, Andrew served as Vice President of Marketing for the Cardio & Vascular (C&V) product category. Prior to joining Integer, he was Director of Program Management for St. Jude Medical. He holds a Master of Business Administration with concentrations in Finance, Marketing & Medical Industry Leadership from the University of Minnesota. He also holds a Master of Science in Technology Management, Bachelor of Science in Mechanical Engineering, and Bachelor of Arts in Business Administration from the University of St. Thomas.
Mac Marshall served as Integer’s Interim General Counsel since September 2021 prior to his appointment as Senior Vice President, General Counsel, Chief Ethics and Compliance Officer and Corporate Secretary. He was formerly SVP, General Counsel and Chief Administrative Officer at The Brink’s Company. Mac has also served as Vice President, General Counsel & Secretary at Tredegar Corporation, and practiced law at the global law firm Hunton and Williams LLP. He holds a Juris Doctor (J.D.) from the University of Virginia School of Law and is a graduate of the Advanced Management Program at Harvard Business School.
About Integer®
Integer Holdings Corporation (NYSE: ITGR) is one of the largest medical device outsource (MDO) manufacturers in the world serving the cardiac, neuromodulation, vascular, portable medical, advanced surgical and orthopedics markets. The company provides innovative, high-quality medical technologies that enhance the lives of patients worldwide. In addition, it develops batteries for high-end niche applications in energy, military, and environmental markets. Greatbatch Medical®, Lake Region Medical® and Electrochem® comprise the company’s brands. Additional information is available at www.integer.net.
# # #